Roche (RHHVF) Projected to Release Earnings on Thursday

Roche (OTCMKTS:RHHVF – Get Free Report) is expected to be posting its resultson Thursday, July 23rd. Analysts expect Roche to announce earnings of $12.51 per share and revenue of $37.6482 billion for the quarter.

Roche Price Performance

Shares of OTCMKTS RHHVF opened at $422.31 on Wednesday. Roche has a 52-week low of $300.15 and a 52-week high of $490.33. The business has a fifty day moving average of $408.97 and a two-hundred day moving average of $420.94.

About Roche

(Get Free Report)

Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.

In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.

Further Reading

• Five stocks we like better than Roche
• Confidence Is Back, But Earnings Show the Consumer Is Being Picky
• AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
• 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
• 3 Photonics Companies Making Quantum Tech Possible